Now I have a thorough understanding of the paper. Let me synthesize the final review.

## Summary

The paper introduces ProteinVista, a 3D CNN that voxelizes full-atom protein structures at 1.0 Å resolution (five heavy-atom channels) and is pre-trained via contrastive alignment to ESM-2 embeddings on ~500K AlphaFold-2 structures. It is evaluated on transporter-substrate prediction (TSP), enzyme-substrate prediction (ESP), and BindingDB IC50 regression, claiming to "outperform sequence transformers" while being compute- and data-efficient.

## Strengths

1. **Full-atom voxelization with continuous Gaussian density** (Section 2.1): Rather than binary occupancy used by prior 3D CNNs, each atom contributes a Gaussian density (σ=1), reducing discretization artifacts and preserving local geometry. This is a concrete design improvement.

2. **Impressive compute and data efficiency, well-documented**: Pre-training on ~500K structures (vs. ~250M sequences for ESM-2) with 123M parameters (vs. 650M), ProteinVista achieves competitive results while using ~1% of the GPU-hours of ESM-2 pre-training (Section 4.3, Figure 3). The 20s vs. 426s per 1K proteins on A100 is a genuine practical advantage.

3. **Stratified analysis is insightful and thorough** (Section 4.1, Figure 2a–d): Partitioning test performance by sequence identity, TM-score, and pLDDT reveals *when* structure helps — high-confidence, structurally similar cases. This is the strongest analytical contribution and provides actionable guidance for practitioners.

4. **Comprehensive ablation validates key design choices** (Section 4.2, Figure 2e): The ablation quantifies the contribution of inference-time ensemble views (−6.4% R² for 1 vs. 5 views), voxel resolution (1.1% drop at 1.5 Å), and pre-training objective (1.0% advantage for contrastive over Rosetta regression). This is thorough and informative.

5. **Intellectually honest negative control** (Section 3.4): The GO term prediction experiment shows ProteinVista underperforms ESM-2 (F_max 0.57 vs. 0.62), correctly interpreted as "limited value for homology-based tasks." Including and properly contextualizing this strengthens credibility.

6. **Adaptive boxing** (Section 2.1): Encoding each protein in the smallest of four grid sizes (64³–160³) directly addresses the sparsity problem that previously limited 3D CNNs for proteins.

## Weaknesses

### Fatal
None. The paper's core claims are not invalidated; no errors in the methodology or results are evident from the paper as presented.

### Major

1. **No comparison to other structure-aware models**: The paper benchmarks ProteinVista only against sequence transformers (ESM-2) and task-specific SOTA methods (SPOT, ProSmith-ESP). Despite discussing GearNet, ESM-GearNet, and prior 3D CNNs (DeepSite, VoroCNN) in the introduction, none are evaluated on the same benchmarks. For a paper whose central claim is that "full-atom 3D CNNs are superior...for structure-dependent tasks," the absence of any comparison to graph-based or equivariant structure encoders is a critical gap. The reader cannot determine whether the gains come from using structure at all or from the specific voxel-based design.

2. **Title and abstract overstate the results on binary classification**: On ESP (enzyme-substrate), ProteinVista achieves 91.8% accuracy vs. ESM-2_650M's 91.9% — essentially identical. On TSP, the gain is modest (+1.5% accuracy, +0.03 MCC). The only clear improvement is on IC50 regression (R² 0.69 vs. 0.61). The claim "outperforms sequence transformers on three benchmarks" conflates two essentially-tied results with one genuinely better result. A more precise claim would distinguish the tasks. Moreover, the SOTA results (Table 1 bottom rows) come from the optimized pipeline ensemble that includes ESM-2, not from ProteinVista alone.

3. **Statistical significance unreported for standalone ProteinVista vs. ESM-2 on binary tasks**: McNemar's test is reported only for the ensemble vs. ESM-2 (p < 10⁻¹³, p < 10⁻¹⁷), not for ProteinVista alone vs. ESM-2. Given the small margin on TSP and the tie on ESP, this omission matters (Section 3.2).

### Minor

4. **Pre-training dependency on ESM-2 partially confounds the independence claim**: The contrastive objective aligns structure embeddings to ESM-2 sequence embeddings (Section 2.3), meaning the structure encoder is directly supervised by a sequence model's representation. The ablation partially addresses this by showing Rosetta regression (no ESM-2) is only ~1% worse, which is good. However, the paper does not quantify embedding similarity between ProteinVista and ESM-2 on held-out data, leaving open the question of how much the model's success stems from ESM-2 mimicry vs. genuine 3D geometry.

5. **Rotation invariance is approximate and sensitivity remains substantial**: Only 90° rotations and mirror reflections are used (Section 2.4). The ablation shows that reducing inference from 5 views to 1 drops R² by 6.4%, confirming significant orientation sensitivity. The paper describes the model as "rotation-robust," but does not test arbitrary rotations or fully characterize the remaining orientation dependence.

6. **Compute speedup vs. FLOPs discrepancy not fully explained**: ProteinVista's 415 GFLOPs vs. ESM-2_650M's 520 GFLOPs is only a 1.25× reduction, yet wall-clock time is 20s vs. 426s (~21× faster). The paper attributes this to "can be parallelized more efficiently" without profiling data or architectural analysis (Section 4.3). A breakdown (e.g., memory bandwidth utilization, kernel efficiency) would substantiate the claim.

7. **Data split procedure not specified**: The paper references a validation set for model selection but does not describe how train/val/test splits were constructed (random, stratified by sequence identity, temporal, etc.). Leakage is a known concern in protein-ligand benchmarking and should be addressed.

### Trivial
None.

## Nice-to-Haves

- **Grad-CAM or attention visualization** (mentioned as future work in Section 5): Visualizing which voxels drive predictions would strengthen the biological plausibility claim and demonstrate the model attends to binding sites.
- **Evaluation on experimental (X-ray) structures** for a subset of test proteins to quantify the impact of using predicted structures.
- **Comparison at finer voxel resolutions** (e.g., 0.5 Å) to probe resolution–accuracy trade-offs beyond the 1.0 Å vs. 1.5 Å comparison already done.

## Removed Points

These points are flagged to be removed; treat them with caution.

- **"The pre-training dependent on ESM-2 is a structural/fatal flaw"** (Harsh Critic Issue 1): The paper's own ablation (Rosetta regression only 1% worse) directly contradicts the "fatal" characterization. The concern is valid at a minor level but not structural/fatal. Moved to Minor weakness #4.
- **"Existence of first compute-efficient claim needs verification"** (Harsh Critic Point 12): This is a speculation about novelty verification that cannot be resolved from the paper alone. Per guidelines, removed as non-substantive.
- **"Section numbering is off; missing sections and figures"** (Harsh Critic Point 13): Parser artifact. Per formatting rules, removed.
- **"The FLOPs-to-time discrepancy is puzzling"**: This is a valid observation but is retained as Minor weakness #6, not removed.
- **"Hydrogen atoms are omitted"** (Harsh Critic Point 10): This is a design choice, not a weakness. The paper explicitly voxelizes only the five most common heavy atoms. Criticizing scope choices is not fair.
- **Strength Finder strengths about "problem importance" or generic praise**: All retained strengths are concrete and specific. No generic strengths were found.
- **"The model is compared to other structure-aware methods only in the introduction"**: Both reviews raise this — merged into Major weakness #1.

## Novel Insights

None beyond the paper's own contributions. The reviews surface a misalignment between the paper's claimed scope ("outperforms") and the actual evidence, but this is a critique of presentation, not a novel observation about the method.

## Suggestions

1. **Add at least one structure-aware baseline**: Evaluate GearNet or a lightweight equivariant network (e.g., one layer of SE(3)-Transformer) on the same TSP/ESP/IC50 benchmarks. This would either strengthen the claim or reveal limitations of the voxel approach.
2. **Temper the title and abstract claims**: Replace "outperforms" with precise language about the specific tasks where improvement is observed (e.g., "competitive with and complementary to sequence transformers").
3. **Report significance tests for standalone ProteinVista vs. ESM-2 on the binary tasks** (McNemar's test).
4. **Report embedding similarity** (e.g., cosine similarity on held-out proteins) between ProteinVista and ESM-2 to quantify how distinct the learned representations are.
5. **Describe the data split strategy** in the experimental setup.
6. **Provide profiling data** explaining the 21× speedup vs. 1.25× FLOPs reduction.

## Score and Decision

**Originality**: Moderate — 3D CNNs for proteins have existed (DeepSite, EnzyNet, VoroCNN), but this is the first large-scale pre-trained version with adaptive boxing and continuous Gaussian occupancy. The contrastive pre-training against ESM-2 is a design choice, not a novelty.

**Importance**: High — structure-aware protein representations are an important direction, and demonstrating compute efficiency is practically valuable.

**Claims well supported**: Partially — well-supported for IC50 and efficiency claims; overstated for binary classification tasks.

**Soundness of experiments**: Good methodology for what is evaluated, but the missing structure-aware baselines are a significant gap.

**Clarity**: Good — well-written, clear methods, thorough analysis.

**Value to community**: Moderate — the open-source implementation and efficiency analysis are useful, but the overclaimed results and missing baselines weaken the impact.

The paper has genuine contributions (efficiency, analysis, design) but the central claim is not uniformly supported by the evidence, and a key comparison class (structure-aware baselines) is absent. A revision addressing these gaps could make this a strong paper.

**MY FINAL SCORE: <score>5.0</score>**
**MY FINAL DECISION: <decision>Reject</decision>**